Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000107

EVP, Chief Technical Ops. Off. sold 1,767 shares at $480.95 ($849,839)

  • EVP, Chief Technical Ops. Off. gave up 1,656 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-24 Shares withheld for taxes : show line 1 in the form 10b5-1 −1,656 $483.28 $800,312 26,251 D
2025-02-25 Sale : show line 2 in the form 10b5-1 −1,767 $480.95 $849,839 24,484 D
Open-market sales · 1,767 sh · avg $480.95 · $849,839
Loading xslF345X05/wk-form4_1740604171.xml…